ClassID:

94371

C07D231/18 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms One oxygen or sulfur atom

Sub-classes:
Recent Application in this class:
#1
20250388568
2025-12-25

NLRP3 INHIBITORS

#2
20250326713
2025-10-23

INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#3
20250312362
2025-10-09

INHIBITORS OF MsbA AS ANTIBIOTICS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF

#4
20250145594
2025-05-08

MODULATORS OF THE INTEGRATED STRESS PATHWAY

#5
20250115618
2025-04-10

SULFONIMIDAMIDE COMPOUNDS AS INHIBITORS OF INTERLEUKIN-1 ACTIVITY

#6
20250025443
2025-01-23

COMPOUNDS AND METHODS FOR TREATING CORONA VIRUSES

#7
20250011288
2025-01-09

RXFP1 AGONISTS

#8
20240409508
2024-12-12

SULFINYLAMINOBENZAMIDE AND SULFONYLAMINOBENZAMIDE DERIVATIVES

#9
20240408093
2024-12-12

HETEROBIFUNCTIONAL COMPOUNDS AND THEIR USE IN TREATING DISEASE

#10
20240400502
2024-12-05

SULFONYLUREAS AND RELATED COMPOUNDS AND USE OF SAME

#11
20240343696
2024-10-17

COMPOUNDS AND USES THEREOF IN THE TREATMENT AND PREVENTION OF DISEASES AND CONDITIONS ASSOCIATE WITH OR AGGRAVATED BY IMPAIRED MITOPHAGY OR OXIDATIVE STRESS

#12
20240336562
2024-10-10

COMPOUND SERVING AS NLRP3 INHIBITOR

#13
20240254078
2024-08-01

Small molecule compounds having naphthylamine structure and application thereof

#14
20240253023
2024-08-01

PERFLUORINATED AMIDE SALTS AND THEIR USES AS IONIC CONDUCTING MATERIALS

#15
20230416211
2023-12-28

Compounds and compositions for treating conditions associated with NLRP activity

#16
20230174470
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

#17
20230174465
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

#18
20230126893
2023-04-27

[(1,4,5-TRISUBSTITUTED-1H-PYRAZOL-3-YL)SULFANYL]ACETIC ACID DERIVATIVES, SALTS THEREOF, AND USE THEREOF AS ACTIVE HERBICIDAL INGREDIENTS

#19
20230114875
2023-04-13

2-amino-N-(amino-oxo-aryl-lambda-sulfanylidene)acetamide compounds and their therapeutic use

#20
20230062815
2023-03-02

Compounds and compositions for treating conditions associated with NLRP activity

#21
20230051589
2023-02-16

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

#22
20220324807
2022-10-13

Aromatic sulfonamide derivatives

#23
20220306630
2022-09-29

AGONISTS OF ROR GAMMAt

#24
20220112159
2022-04-14

Sulfonylureas and related compounds and use of same

#25
20220106289
2022-04-07

NLRP3 INHIBITORS

#26
20220073452
2022-03-10

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#27
20220055985
2022-02-24

Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives

#28
20220017472
2022-01-20

Arylazole compound and pest control agent

#29
20210347737
2021-11-11

Compounds

#30
20210284606
2021-09-16

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#31
20210253596
2021-08-19

Sulfonimidamide compounds as inhibitors of interleukin-1 activity

#32
20210253533
2021-08-19

DISUBSTITUTED 5(3)-PYRAZOLE CARBOXYLATES AND A PROCESS FOR THEIR PREPARATION FROM ENOLATES AND FLUOROALKYLAMINOREAGENTS (FAR) REAGENTS

#33
20210206726
2021-07-08

Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

#34
20210171477
2021-06-10

Compounds and compositions for treating conditions associated with NLRP activity

#35
20210155576
2021-05-27

Neprilysin inhibitors

#36
20210130359
2021-05-06

Sulfonylureas and sulfonylthioureas as NLRPinhibitors

#37
20210122739
2021-04-29

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

#38
20210114990
2021-04-22

DISUBSTITUTED 3-PYRAZOLE CARBOXYLATES AND A PROCESS FOR THEIR PREPARATION VIA ACYLATION OF ENOLATES

#39
20210053940
2021-02-25

Pyrazole compounds and preparation thereof

#40
20210053915
2021-02-25

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#41
20210040065
2021-02-11

Compounds

#42
20210040043
2021-02-11

HALOGEN SUBSTITUTED DIKETONES, PYRAZOLE COMPOUNDS AND PROCESSES FOR THE MANUFACTURE OF PYRAZOLE COMPOUNDS

#43
20200399243
2020-12-24

Sulfonyl acetamides as NLRP3 inhibitors

#44
20200392123
2020-12-17

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

#45
20200392116
2020-12-17

Substituted heterocycles as c-MYC targeting agents

#46
20200361895
2020-11-19

NOVEL SULFONAMIDE CARBOXAMIDE COMPOUNDS

#47
20200331886
2020-10-22

Compounds

#48
20200331880
2020-10-22

Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia

#49
20200331847
2020-10-22

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#50
20200317637
2020-10-08

Sulfonamide carboxamide compounds

#51
20200308119
2020-10-01

Pyrazole compound

#52
20200262794
2020-08-20

GLYCOLATE OXIDASE INHIBITORS AND METHODS OF USE FOR THE TREATMENT OF KIDNEY STONES

#53
20200247761
2020-08-06

SULFONAMIDE OR AMIDE COMPOUNDS, COMPOSITIONS AND METHODS FOR THE PROPHYLAXIS AND/OR TREATMENT OF AUTOIMMUNE, INFLAMMATION OR INFECTION RELATED DISORDERS

#54
20200223794
2020-07-16

High solubility thioether quinones

#55
20200131200
2020-04-30

Spiroheptane salicylamides and related compounds as inhibitors of ROCK

#56
20200115333
2020-04-16

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#57
20200087253
2020-03-19

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#58
20200069648
2020-03-05

HALOALLYLAMINE PYRAZOLE DERIVATIVE INHIBITORS OF LYSYL OXIDASES AND USES THEREOF

#59
20200017436
2020-01-16

Neprilysin inhibitors

#60
20190359565
2019-11-28

Sulfinylaminobenzamide and sulfonylaminobenzamide derivatives

#61
20190359564
2019-11-28

Sulfonylureas and related compounds and use of same

#62
20190352269
2019-11-21

Method for producing a polymorphic form of 3-[5-amino-4-(3- cyanobenzoyl)-pyrazol-1-yl]-N-cyclopropyl-4-methylbenzamide

#63
20190337915
2019-11-07

Amide compounds and use thereof

#64
20190332023
2019-10-31

Electrophotographic photosensitive member, process cartridge, and image forming apparatus

#65
20190270731
2019-09-05

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

#66
20190269652
2019-09-05

N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the κ opioid receptor

#67
20190241506
2019-08-08

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#68
20190152940
2019-05-23

Pyridyl reverse sulfonamides for HBV treatment

#69
20190144380
2019-05-16

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#70
20190119241
2019-04-25

Compounds and compositions for treating conditions associated with NLRP activity

#71
20190119210
2019-04-25

Aromatic sulfonamide derivatives

#72
20190084938
2019-03-21

Pyrazole compound

#73
20190062281
2019-02-28

Substituted heterocycles as c-MYC targeting agents

#74
20190055193
2019-02-21

High-solubility thioether quinones

#75
20190031616
2019-01-31

Halogen substituted diketones, pyrazole compounds and processes for the manufacture of pyrazole compounds

#76
20190015387
2019-01-17

Selective androgen receptor degrader (SARD) ligands and methods of use thereof

#77
20180362470
2018-12-20

Arylazole compound and pest control agent

#78
20180327350
2018-11-15

Neprilysin inhibitors

#79
20180319743
2018-11-08

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#80
20180297939
2018-10-18

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#81
20180273489
2018-09-27

Pyrazole compound

#82
20180244610
2018-08-30

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#83
20180235222
2018-08-23

Penflufen polymer particles

#84
20180127368
2018-05-10

Tricyclic sulfones as ROR gamma modulators

#85
20180086738
2018-03-29

Pyrazole compounds or salts thereof, preparation method therefor, herbicidal composition and use thereof

#86
20180051000
2018-02-22

Pyridyl reverse sulfonamides for HBV treatment

#87
20180050052
2018-02-22

Neprilysin inhibitors

#88
20180044287
2018-02-15

Sulfonylureas and related compounds and use of same

#89
20180044282
2018-02-15

ALPHA-CINNAMIDE COMPOUNDS AND COMPOSITIONS AS HDAC8 INHIBITORS

#90
20180042234
2018-02-15

FUNGICIDAL PYRAZOLES

#91
20180030039
2018-02-01

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

#92
20170368029
2017-12-28

N-methyl-N-(1-phenyl-2-(1-pyrrolidinyl)ethyl)-2-aminophenylacetamide derivatives agonists for the kappa opioid receptor

#93
20170355664
2017-12-14

Neprilysin inhibitors

#94
20170349552
2017-12-07

Substituted pyrazolone compounds for use in treatment of amyotrophic lateral sclerosis

#95
20170334841
2017-11-23

TETRACYCLINE COMPOUNDS

#96
20170305847
2017-10-26

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#97
20170253581
2017-09-07

SUBSTITUTED HETEROCYCLES AS c-MYC TARGETING AGENTS

#98
20170247321
2017-08-31

TETRALIN AND INDANE DERIVATIVES AND USES THEREOF

#99
20170226097
2017-08-10

Pyridinyloxy- and phenyloxy-pyrazolyl compounds

#100
20170223960
2017-08-10

Halogen-substituted compounds

#101
20170217902
2017-08-03

Pyrazole compound

#102
20170183333
2017-06-29

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

#103
20170050979
2017-02-23

Small molecule inhibitors of G protein coupled receptor 6 kinases polypeptides

#104
20170022154
2017-01-26

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#105
20170020904
2017-01-26

Neprilysin inhibitors

#106
20170014395
2017-01-19

Endoparasite control agent and method for using the same

#107
20160331782
2016-11-17

Heteroaryl disulfide compounds as allosteric effectors for increasing the oxygen-binding affinity of hemoglobin

#108
20160289195
2016-10-06

Fluorophenyl pyrazol compounds

#109
20160264518
2016-09-15

Alpha-cinnamide compounds and compositions as HDAC8 inhibitors

#110
20160228407
2016-08-11

1,2- bis-sulfonamide derivatives as chemokine receptor modulators

#111
20160212998
2016-07-28

Fungicidal pyrazoles

#112
20160185748
2016-06-30

Pyridyl reverse sulfonamides for HBV treatment

#113
20160016911
2016-01-21

Treatment of amyotrophic lateral sclerosis

#114
20160002187
2016-01-07

Apoptosis-inducing agent for the treatment of cancer and immune and autoimmune diseases

#115
20160002148
2016-01-07

Neprilysin inhibitors

#116
20150361075
2015-12-17

Compounds that modulate intracellular calcium

#117
20150353500
2015-12-10

Halogen-substituted pyrazole derivatives as pest-control agents

#118
20150266859
2015-09-24

Glucagon receptor modulators

#119
20150266817
2015-09-24

Tetralin and indane derivatives and uses thereof

#120
20150259322
2015-09-17

Endoparasite control agent and method for using the same

#121
20150259282
2015-09-17

Potassium channel blockers

#122
20150210690
2015-07-30

Neprilysin inhibitors

#123
20150210635
2015-07-30

Compound having ability to inhibit 11Beta-HSD1 enzyme or pharmaceutically acceptable salt thereof, method for producing same, and pharmaceutical composition containing same as active ingredient

#124
20150197509
2015-07-16

Substituted sulfonamide compounds

#125
20150191455
2015-07-09

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

#126
20150133506
2015-05-14

1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof

#127
20150126493
2015-05-07

Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of disease

#128
20150073153
2015-03-12

Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds

#129
20150051233
2015-02-19

Methods and compositions for treatment of fibrosis

#130
20150024032
2015-01-22

Methods and compositions for treatment of muscle wasting, muscle weakness, and/or cachexia

#131
20150018561
2015-01-15

CFO-containing enaminoketones and their utilization for the preparation of CFO-containing pyrazoles

#132
20140378466
2014-12-25

DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK

#133
20140371467
2014-12-18

Glucagon receptor modulators

#134
20140364603
2014-12-11

Neprilysin inhibitors

#135
20140350267
2014-11-27

Process for the preparation of N-substituted pyrazole compounds

#136
20140315971
2014-10-23

Pyrazole compound

#137
20140309206
2014-10-16

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

#138
20140275037
2014-09-18

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses

#139
20140256701
2014-09-11

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#140
20140243366
2014-08-28

Compounds that modulate intracellular calcium

#141
20140221448
2014-08-07

Fungicidal pyrazoles

#142
20140221337
2014-08-07

Potassium channel blockers

#143
20140206738
2014-07-24

ATGListatin and pharmaceutical composition comprising the same

#144
20140171469
2014-06-19

Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto

#145
20140088158
2014-03-27

Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals

#146
20140088153
2014-03-27

N-(3-carbamoylphenly)-1H-pyrazole-5-carboxamide derivatives and the use thereof for controlling animal pests

#147
20140081030
2014-03-20

O-cyclopropylcyclohexyl-carboxanilides and their use as fungicides

#148
20140073799
2014-03-13

Thienopyrazole derivative having PDE7 inhibitory activity

#149
20140051857
2014-02-20

HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS

#150
20140031331
2014-01-30

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#151
20130330366
2013-12-12

Neprilysin inhibitors

#152
20130324457
2013-12-05

1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof

#153
20130296355
2013-11-07

Glucagon receptor modulators

#154
20130281710
2013-10-24

Processes for the preparation of 1-aryl-5-alkyl pyrazole compounds

#155
20130261316
2013-10-03

Neprilysin inhibitors

#156
20130261120
2013-10-03

Substituted N-(2-arylamino)aryl sulfonamide-containing combinations

#157
20130210883
2013-08-15

LIPASE INHIBITORS

#158
20130184278
2013-07-18

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#159
20130184238
2013-07-18

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#160
20130143940
2013-06-06

Fungicidal pyrazoles

#161
20130072536
2013-03-21

Pyrazole compounds that modulate HSP90 activity

#162
20130012708
2013-01-10

HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS

#163
20120264790
2012-10-18

Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals

#164
20120225854
2012-09-06

Compounds that interact with glucokinase regulatory protein for the treatment of diabetes

#165
20120213806
2012-08-23

Neprilysin inhibitors

#166
20120209005
2012-08-16

Fused heterocyclic compounds and thrombopoietin receptor activators

#167
20120208788
2012-08-16

Tetracycline compounds

#168
20120202834
2012-08-09

Glucagon receptor modulators

#169
20120202816
2012-08-09

Pyrazole-based thyroid receptor compounds

#170
20120202781
2012-08-09

Indane derivatives

#171
20120196884
2012-08-02

UREA SUBSTITUTED SULPHONAMIDE DERIVATIVES

#172
20120157444
2012-06-21

1,2-bis-sulfonamide derivatives as chemokine receptor modulators

#173
20120149710
2012-06-14

SORTASE A INHIBITORS

#174
20120122780
2012-05-17

Compounds, Compositions and Methods for Modulating Uric Acid Levels

#175
20120108573
2012-05-03

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

#176
20120088837
2012-04-12

Tetralin and indane derivatives and uses thereof

#177
20120077796
2012-03-29

Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy

#178
20120071489
2012-03-22

Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes

#179
20120041043
2012-02-16

Sulfonamide compounds for the treatment of respiratory disorders

#180
20120040948
2012-02-16

Aminoindane derivatives, pharmaceutical compositions containing them, and their use in therapy

#181
20120029192
2012-02-02

Pyrazole Derivatives

#182
20120022076
2012-01-26

Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK

#183
20110306646
2011-12-15

Fungicidal N-(Phenylcycloalkyl)carboxamide, N-(Benzylcycloalkyl)carboxamide and thiocarboxamide derivatives

#184
20110306614
2011-12-15

N-Hydroxylsulfonamide Derivatives as New Physiologically Useful Nitroxyl Donors

#185
20110245157
2011-10-06

Dimeric 1-arylpyrazole derivatives for use against ectoparasites, agricultural pests, and household pests

#186
20110224273
2011-09-15

Pyrazole derivatives as 11-beta-HSD1 inhibitors

#187
20110224262
2011-09-15

PYRAZOLYL SUBSTITUTED CARBONIC ACID DERIVATIVES AS MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO

#188
20110190365
2011-08-04

Insecticidal 4-phenyl-1H-pyrazoles

#189
20110166343
2011-07-07

THIENOPYRAZOLE DERIVATIVE HAVING PDE7 INHIBITORY ACTIVITY

#190
20110144332
2011-06-16

Pyrazole compounds that modulate HSP90 activity

#191
20110144056
2011-06-16

PYRAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH

#192
20110092539
2011-04-21

Indane derivatives as AMPA receptor modulators

#193
20110077290
2011-03-31

Heterocyclic compounds and thrombopoietin receptor activators

#194
20110071125
2011-03-24

SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY

#195
20110065682
2011-03-17

Heterocyclic compounds as factor IXA inhibitors

#196
20110039819
2011-02-17

SUBSTITUTED PHENOXYBENZAMIDES

#197
20100273739
2010-10-28

Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy

#198
20100267964
2010-10-21

N-HETEROCYCLYLPHENYL-SUBSTITUTED CYCLIC KETOENOLS

#199
20100249194
2010-09-30

1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof

#200
20100240659
2010-09-23

Nitrogen-containing heterocyclic derivative having 11β-hydroxysteroid dehydrogenase type I inhibitory activity

#201
20100240618
2010-09-23

Substituted piperazines

#202
20100210696
2010-08-19

5-Membered heterocyclic compound

#203
20100189648
2010-07-29

INHIBITORS FOR DISRUPTING THE INTERACTION OF UBIQUITINATION RELATED ENZYMES AND USES THEREOF

#204
20100184766
2010-07-22

Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

#205
20100168110
2010-07-01

Thyroid like compounds

#206
20100130743
2010-05-27

HETEROCYCLE-SUBSTITUTED, N-PHENYL-PHTHALAMIDE DERIVATIVES, RELATED COMPOUNDS AND THEIR USE AS INSECTICIDES

#207
20100087438
2010-04-08

Potassium channel blockers

#208
20100087437
2010-04-08

Potassium channel blockers

#209
20100087428
2010-04-08

Potassium channel blockers

#210
20100069442
2010-03-18

PYRAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY

#211
20100029726
2010-02-04

Cyclohexanesulfonyl derivatives as GLYT1 inhibitors to treat schizophrenia

#212
20100029609
2010-02-04

BIARYL SULFONAMIDE DERIVATIVES

#213
20100016396
2010-01-21

PYRAZOLE COMPOUND

#214
20090227667
2009-09-10

Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof

#215
20090221663
2009-09-03

Chemical compounds

#216
20090215712
2009-08-27

Pyrazole derivatives

#217
20090203675
2009-08-13

Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arena viruses

#218
20090186924
2009-07-23

Substituted arylpyrazoles

#219
20090170832
2009-07-02

Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity

#220
20090156642
2009-06-18

5-Membered heterocyclic compound

#221
20090149445
2009-06-11

TRICYCLIC STEROID HORMONE NUCLEAR RECEPTOR MODULATORS

#222
20090143370
2009-06-04

Non-nucleoside reverse transcriptase inhibitors

#223
20090131659
2009-05-21

Amide compound and thrombopoietin receptor activator

#224
20090131433
2009-05-21

Histamine-3 receptor antagonists

#225
20090131413
2009-05-21

Thienopyrazole derivative having PDE7 inhibitory activity

#226
20090099209
2009-04-16

Compounds Useful in Therapy

#227
20090093485
2009-04-09

Novel Sulphonamide Derivatives as Glucocorticoid Receptor Modulators for the Treatment of Inflammatory Diseases

#228
20090082457
2009-03-26

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#229
20090082328
2009-03-26

Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity

#230
20090048256
2009-02-19

Pyrazole compounds having cannabinoid receptor (CB1) antagonizing activity

#231
20080293751
2008-11-27

Tetralin and indane derivatives and uses thereof

#232
20080261987
2008-10-23

Substituted piperazines

#233
20080200527
2008-08-21

Cannabinoid Receptor Modulators

#234
20080096936
2008-04-24

Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them

#235
20080090880
2008-04-17

3-(2-Hydroxyphenyl) Pyrazoles and Thier Use as Hsp90 Modulators

#236
20080090875
2008-04-17

Thione derivative, method for the preparation thereof, and pharmaceutical composition containing the same

#237
20080085919
2008-04-10

1H-pyrazoles useful in therapy

#238
20080058340
2008-03-06

Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK

#239
20080045516
2008-02-21

Viral polymerase inhibitors

#240
20080031902
2008-02-07

1-aryl-5-alkyl pyrazole derivative compounds, processes of making and methods of using thereof

#241
20080027068
2008-01-31

Heterocyclic compounds and thrombopoietin receptor activators

#242
20070299107
2007-12-27

N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors

#243
20070299085
2007-12-27

Heterocycle-substituted n-phenyl-phthalamide derivatives, related compounds and their use as insecticides

#244
20070260056
2007-11-08

Process for Preparing Bicyclic Pyrazolyl

#245
20070254929
2007-11-01

Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof

#246
20070203245
2007-08-30

ABCA1 elevating compounds

#247
20070203224
2007-08-30

SMALL-MOLECULES FOR TREATING CANCER AND ABNORMAL CELL PROLIFERATION DISORDERS

#248
20070191445
2007-08-16

Pyrazole compounds that modulate HSP90 activity

#249
20070167655
2007-07-19

Method for the production of tetrahydrogeranylacetone

#250
20070105909
2007-05-10

1H-pyrazoles useful in therapy

#251
20060287365
2006-12-21

Substituted arylpyrazoles

#252
20060276655
2006-12-07

Cyclohexanesulfonyl derivatives as GlyT1 inhibitors to treat schizophrenia

#253
20060276518
2006-12-07

Aryl and heteroaryl compounds and methods to modulate coagulation

#254
20060241125
2006-10-26

Compounds useful in therapy

#255
20060223829
2006-10-05

Hydroxysteroid dehydrogenase inhibitors

#256
20060217433
2006-09-28

Sulfonamide derivatives as PPAR modulators

#257
20060183780
2006-08-17

Pyrazole compounds useful in the treatment of inflammation

#258
20060167255
2006-07-27

Tetralin and indane derivatives and uses thereof

#259
20060166829
2006-07-27

N-heterocyclyl phenyl-substituted cyclic ketoenols

#260
20060160803
2006-07-20

Cinnamide and hydrocinnamide derivatives with kinase inhibitory activity

#261
20060135770
2006-06-22

PARP inhibitors

#262
20060135601
2006-06-22

Hexafluoroisopropanol substituted cyclohexane derivatives

#263
20060128568
2006-06-15

3-cyclopropyl-4-(3-amino-2-methylbenzoyl)pyrazoles and their use as herbicides

#264
20060106218
2006-05-18

Substituted piperazines

#265
20060094694
2006-05-04

Heterocyclic compounds and thrombopoietin receptor activators

#266
20060063759
2006-03-23

Tricyclic steroid hormone nuclear receptor modulators

#267
20060020012
2006-01-26

Pyrazole derivatives

#268
20050282907
2005-12-22

Non nucleoside reverse transcriptase inhibitors

#269
20050272745
2005-12-08

Novel piperidine and piperazine derivatives

#270
20050261276
2005-11-24

Sulphones for inhibition of gamma secretase

#271
20050256130
2005-11-17

Substituted piperazines

#272
20050239655
2005-10-27

3-Heterocyclyl substituted benzoic acid derivatives

#273
20050221990
2005-10-06

Novel benzohydrazide derivatives as herbicides and desiccant compositions contaning them

#274
20050154056
2005-07-14

Inhibitors of HCV NS5B polymerase

#275
20050150764
2005-07-14

Tetrahydropyridazine derivatives and their use as pesticides

#276
20050123831
2005-06-09

Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials

#277
20050119489
2005-06-02

4-Sulfide/sulfoxide/sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor

#278
20050119246
2005-06-02

1H-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor

#279
20050074668
2005-04-07

Perfluorinated amide salts and their uses as ionic conducting materials

#280
20050054707
2005-03-10

Pyrazole derivatives